HIV/AIDS Policy: HIV/AIDS Drug Patents

Show Archived (Historical) Articles

Pharmaceutical Companies Accept Ecuador's Decision to Break Drug Patents (October 29, 2009)
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
MSF Calls on Drug Companies to Pool HIV Patents (October 5, 2009)
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
Drug Companies Called on to Pool HIV Patents (September 30, 2009)
From Médecins Sans Frontières
Canada: Hope for Cheap HIV Drugs Dims (September 21, 2009)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
GlaxoSmithKline Spokesman Defends Company's Position on Patent Pools for HIV in Guardian Letter to the Editor (September 10, 2009)
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
Indian Health Officials Welcome Patent Rejections of HIV/AIDS Drugs (September 9, 2009)
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
Organizations Call on GSK to Join UNITAID Patent Pool (September 9, 2009)
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
Drug Patents Come Under Fire at AIDS Conference (August 16, 2009)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Agency for Health Care Policy and Research
Lancet Commends U.K. All-Parliamentary Group on AIDS Call For HIV Drug Patent Pool (July 24, 2009)
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
Glaxo Proposes Patent Pool for Neglected Diseases (February 17, 2009)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
Brazil May Reject Gilead's AIDS Drug Patent (April 11, 2008)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
Thai-Ing to Change the System (February 22, 2008)
U.S. advocates join call for Thailand to stand up to PhRMA and continue life-saving generic drug program.
In Housing Works AIDS Issues Update, from Housing Works
Gilead Sciences May Lose Patent for Viread (January 25, 2008)
Looser patent laws could mean generic version of Tenofovir to come.
In Housing Works AIDS Issues Update, from Housing Works
India's Decision to Adhere to International Patent Regulations Could Limit Access to Medicines, Including HIV/AIDS Drugs (January 8, 2007)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
Developing Countries Should Use Trade Rules to Circumvent Patent Laws on AIDS Drugs, WHO Official Says (September 23, 2005)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
Congress Should Vote Down CAFTA Because of Patent Protections on Drugs, Including Antiretrovirals, Opinion Piece Says (May 27, 2005)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
Patent Primer (February 2002)
In GMHC Treatment Issues, from Gay Men's Health Crisis
Making Patents Public: Redefining Intellectual Property When AIDS Drugs Are at Issue (October 11, 2001)
From FindLaw.com
Africa Access: Moving Fast, Outcome Uncertain (February 23, 2001)
In AIDS Treatment News, from AIDS Treatment News
GATT and the Gap: How to Save Lives (November 20, 1998)
How the Global Agreement on Tariffs and Trade could affect treatment access in developing countries.
From AIDS Treatment News

My Health Tracker

Widgets and RSS Feeds

U.S. ASO Finder

The First Man to Be Cured of AIDS: An Update on the Amazing Story -- This Month in HIV

In Search of a Cure: Working to Turn on HIV

HIV Antiretrovirals in Development: An Update From ICAAC 2009

Obama Announces Ryan White CARE Act Reauthorization, Elimination of HIV Travel Ban

AIDS Criminals and Innocent Victims: Is There Anything Wrong With This Picture? A Blog Entry by Catherine Hanssens, Esq.

More >>

The Body is a service of Body Health Resources Corporation, 250 West 57th Street, New York, NY 10107. The Body and its logos are trademarks of Body Health Resources Corporation, which owns the copyright of The Body's homepage, topic pages, page designs and HTML code. General Disclaimer: The Body is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through The Body should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.